Omalizumab increased amounts of common foods that food-allergic kids could eat without an allergic reaction

Tuesday, December 19, 2023 Antibody Reduces Allergic Reactions to Multiple Foods in NIAID Trial Young children eating lunch at school. Credit: Adobe Stock Treatment with a monoclonal antibody significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume without an allergic reaction, a planned interim analysis of NIAID's OUtMATCH trial found. Study participants who received the antibody injections could eat higher doses of peanut, egg, milk and cashew without allergic reactions than participants who received placebo injections. More detailed information about the findings will become available when they are published in a peer-reviewed journal. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107